What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“I have been able to work on a project focused on studying novel cell lines generated from patient with rare undifferentiated sarcomas in children, but also have had the opportunity to shadow in the clinic on a couple of occasions. This experience has awoken the idea of possibly pursing a career as a physician scientist and/or many other options that I had not considered in the past as career choices.”

Bryan Kynnap, Health Sciences, ’16


Trainee Spotlight


Mia Wallach

Business (w Concentration in Healthcare Management and Consulting), '23

Nano-Talazoparib and Nano-Dinaciclib Combination Therapy for Lung Cancer Cells

Holly Chadwick

Behavioral Neuroscience, '23

In vivo investigation of the pathogenesis and development of pituitary adenomas in relation to the loss of MEG3 expression

Kevin Lin

Health Science, '21

Granzyme B Peptide as a Non-invasive Theranostic Agent

Featured Trainee Publication


Upcoming Events

Enzymatic Noncovalent Synthesis for Biomaterials

Tuesday, February 25, 2020

Bing Xu, Ph.D. Professor, Department of Chemistry, Brandeis University

115 Snell Library -- NEU, 3:25 PM


Mentor Spotlight


William Hahn, M.D., Ph.D.

Associate Professor of Medicine, HMS

We have a longstanding interest in cooperative genetic alterations that program malignant transformation and has developed many experimental model systems to study specific genetic alterations. Students will use therapeutic tumor-penetrating siRNA nanocomplexes to identify, validate, and understand potential therapeutic cancer.


Ross I Berbeco, Ph.D.

Associate Professor of Radiation Oncology, HMS

Our lab performs theoretical and experimental studies of systemically administered nanoparticles and their role in enhancing radiation therapy for cancer treatment. Students will have the opportunity to functionalize these particles with tumor-specific targeting moieties and study how this leads to localized disruption of the tumor vasculature.


Trainee Spotlight


Holly Chadwick

Behavioral Neuroscience, '23

In vivo investigation of the pathogenesis and development of pituitary adenomas in relation to the loss of MEG3 expression

Claire Buxton

Molecular Biology, '21

Role of ESRP1/ESRP2 splicing regulators in the development of Triple-Negative Breast Cancer

Kevin Lin

Health Science, '21

Granzyme B Peptide as a Non-invasive Theranostic Agent


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...